Physician

Adina E Schneider, MD

According to 2025 Medicare claims, Adina Schneider, MD (NPI: 1831167790) practices endocrinology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is ENDOCRINE ASSOCIATES OF NASSAU &QUEENS,P.C. (NPI: 1518902915; TIN: 113170859) and primary practice location at 11021-5113. Schneider is affiliated with the CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under the REACH model.

Schneider's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 539 traditional Medicare patients, billed 11,627 HCPCS/CPT codes, and received $316,910 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,944 prescription claims across 436 beneficiaries totaling $1,499,759 in drug costs, led by Ozempic (Semaglutide). DME data shows 375 claims. Open Payments data shows 4 records totaling $74. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $124,983 to $316,910. Similarly, Part D prescription costs have risen steadily, from $558,804 to $1,499,759. For DME billing, reported payments moved sharply higher in recent years, from $7,360 to $106,055.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	332	4,488	$124,983
2016	380	5,211	$144,492
2017	377	5,835	$160,977
2018	383	5,604	$161,598
2019	434	5,754	$178,132
2020	388	4,153	$135,813
2021	466	5,549	$202,493
2022	498	6,547	$218,983
2023	526	14,688	$326,042
2024	539	11,627	$316,910

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	339	2,147	$558,804
2016	316	2,170	$664,476
2017	329	2,148	$813,548
2018	349	2,254	$740,700
2019	375	2,238	$851,895
2020	352	2,257	$1,058,799
2021	363	2,208	$786,760
2022	401	2,353	$949,544
2023	420	2,631	$1,339,460
2024	436	2,944	$1,499,759

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	231	534	$13,767
2016	224	513	$13,156
2017	170	363	$6,644
2018	179	407	$22,049
2019	143	458	$34,625
2020	142	416	$30,790
2021	131	420	$38,837
2022	132	485	$54,960
2023	161	589	$79,762
2024	115	375	$99,244

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	421	866	$112
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	132	$80
G0444	Annual depression screening, 5 to 15 minutes	179	179	$23
83036	Hemoglobin a1c level	218	478	$10
82962	Blood glucose (sugar) test performed by hand-held instrument	242	617	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	336	12,973	$410,933
Mounjaro	Tirzepatide	272	9,076	$325,325
Jardiance	Empagliflozin	143	8,310	$159,253
Januvia	Sitagliptin Phosphate	52	4,080	$74,676
Trulicity	Dulaglutide	44	1,684	$55,619

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	52	223	$94,982
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	11	$2,684
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	42	94	$1,517
A4259	Lancets, per box of 100	N	21	47	$61

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$74	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adina E. Schneider, MD?

Tedicare shows public-source Medicare data for Adina E. Schneider, MD (NPI 1831167790), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adina E. Schneider, MD have ACO affiliation data?

Adina E. Schneider, MD is shown with ACO affiliation data for CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Adina E. Schneider, MD?

Adina E. Schneider, MD is linked to ENDOCRINE ASSOCIATES OF NASSAU &QUEENS,P.C. (billing NPI 1518902915) in the available physician profile data.

Does Adina E. Schneider, MD have Open Payments data?

Adina E. Schneider, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.